Vitamin D: A natural inhibitor of multiple sclerosis

Proceedings of the Nutrition Society

Volumn 59, Issue 4, 2000, Pages 531-535

  Hayes, C E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

1,25 Dihydroxycholecalciferol; Autoimmunity; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Vitamin D

Indexed keywords

CALCITRIOL; CYTOKINE; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA1;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; DEMYELINATING DISEASE; DIET SUPPLEMENTATION; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HUMAN; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; RISK FACTOR; SOLAR RADIATION; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY; VITAMIN INTAKE;

EID: 0034532265     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0029665100000768     Document Type: Article

References (54)

1. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables
2. Viral infections trigger multiple sclerosis relapses: A prospective seroepidemiological study
3. A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis
4. 3
5. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis
6. Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice
7. 3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-β1 and IL-4
8. The etiology of rickets in infants: Prophylactic and curative observations at the Vienna University Kinderklinik
9. Fracture history and bone loss in patients with MS
10. Multiple sclerosis from the standpoint of geographic distribution and race
11. The pathogenesis of multiple sclerosis
12. A population-based twin study in multiple sclerosis
13. Genetics of multiple sclerosis
14. The role of genetic factors in multiple sclerosis susceptibility
15. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus
16. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese
17. The Climate Near the Ground
18. Multiple sclerosis: Vitamin D and calcium as environmental determinants of prevalence (a viewpoint). Part 1: Sunlight, dietary factors and epidemiology
19. Multiple sclerosis: Vitamin D and calcium as environmental determinants of prevalence (a viewpoint). Part 2: Biochemical and Genetic Factors
20. Multiple sclerosis: Decreased relapse rate through dietary supplementation with calcium, magnesium, and vitamin D
21. The age-range of risk of developing multiple sclerosis. Evidence from a migrant population in Australia
22. The vitamin D hormone and its nuclear receptor: Molecular actions and disease states
23. Vitamin D and multiple sclerosis
24. Cure of infantile rickets by sunlight
25. Environmental factors that influence the cutaneous production of vitamin D
26. Vitamin D requirements for humans of all ages: New increased requirements for women and men 50 years and older
27. 3 metabolically active in the intestine
28. In vivo administration of IL-4 induces TGF-beta-producing cells and protects animals from experimental autoimmune encephalomyelitis
29. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1
30. The frequency and geographic distribution of multiple sclerosis as indicated by mortality statistics and morbidity surveys in the United States and Canada
31. On the fine structure of the distribution of multiple sclerosis
32. Protective effect of transforming growth factor b1 on experimental autoimmune diseases in mice
33. 3 suppresses the in vivo induction of murine experimental autoimmune encephalomyelitis
34. Geographic distribution of multiple sclerosis and its estimated prevalence in the US
35. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians
36. Redefining vitamin D insufficiency
37. 1,25-Dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis
38. 1,25-dihydroxycholecalciferol: Identification of the proposed active form of vitamin D3 in the intestine
39. Progress in determining the causes and treatment of multiple sclerosis
40. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis
41. Experimental disseminated encephalomyelitis in white mice
42. Influence of infection on exacerbations of multiple sclerosis
43. The familial incidence of multiple sclerosis and its significance
44. Report on the multiple sclerosis investigations in West Norway
45. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1
46. Clinical viral infections and multiple sclerosis
47. Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients
48. Multiple sclerosis in rural Norway: Its geographic and occupational incidence in relation to nutrition
49. Geographic distribution of multiple sclerosis
50. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety
51. Chimie organique-equilibre de reaction entre precalciferol et calciferol
52. Influence of season and latitude on the cutaneous synthesis of vitamin D3: Exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin
53. Distribution and mortality time trend of multiple sclerosis and some other diseases of Norway